AltrixBio has developed LuCI™, a novel substance that transiently coats the GI mucosa to block nutrient absorption, independent of the pH environment, temporarily mimicking the effects of Gastric Bypass (RYGB). LuCI is comprised of a sucrose octasulfate aluminum complex engineered into a complex coacervate formulation linked via pH-independent electrostatic interactions. LuCI™ AJN 003 a reformulated drug with a 30-year safety profile in peptic ulcers which we have modified for T2D.